PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24978194-5	2014	After in vivo treatment with fadrozole, the size (cellular and nuclear areas) of prolactin cells, as well as the percentage of prolactin-positive cells and the percentage of proliferating-prolactin cells, was significantly decreased.	Fadrozole	29-38	prolactin	Rattus norvegicus	81-90	
24978194-5	2014	After in vivo treatment with fadrozole, the size (cellular and nuclear areas) of prolactin cells, as well as the percentage of prolactin-positive cells and the percentage of proliferating-prolactin cells, was significantly decreased.	Fadrozole	29-38	prolactin	Rattus norvegicus	127-136	
24978194-5	2014	After in vivo treatment with fadrozole, the size (cellular and nuclear areas) of prolactin cells, as well as the percentage of prolactin-positive cells and the percentage of proliferating-prolactin cells, was significantly decreased.	Fadrozole	29-38	prolactin	Rattus norvegicus	127-136	
24978194-6	2014	Moreover, fadrozole decreased serum prolactin levels.	Fadrozole	10-19	prolactin	Rattus norvegicus	36-45	
24978194-7	2014	In vitro, treatment with fadrozole plus testosterone induced similar effects on prolactin-positive cells, inhibiting their cellular proliferation.	Fadrozole	25-34	prolactin	Rattus norvegicus	80-89